Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Mometasone Furoate Nasal Spray

Mometasone Furoate Nasal Spray

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Mometasone Furoate Nasal Spray

21 trials tracked of Mometasone Furoate Nasal Spray: 18 in phase 3 or 4 and 1 with published results. The most-cited published study has 20 citations.

21Trials tracked
18Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 4 Phase 3 14 Phase 2 2 Other / NA 1
  1. Phase 3 Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Completed · 20 cited
  2. Phase 4 The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) Completed
  3. Phase 4 Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED) Completed
  4. Phase 4 This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED) Completed
  5. Phase 4 Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367) Completed
  6. Phase 3 Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145) Completed
Show 15 more trials
  1. Phase 3 Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161) Completed
  2. Phase 3 Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184) Completed
  3. Phase 3 An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma Completed
  4. Phase 3 Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292) Completed
  5. Phase 3 Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps Completed
  6. Phase 3 Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED) Completed
  7. Phase 3 S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps Completed
  8. Phase 3 A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604) Completed
  9. Phase 3 Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED) Completed
  10. Phase 3 Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155) Completed
  11. Phase 3 Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529) Completed
  12. Phase 3 Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583) Completed
  13. Phase 2 An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis Completed
  14. Phase 2 Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Completed
  15. N/A Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis? Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.